Press Releases SCHOTT Pharma AG & Co. KGaA Deutsche Boerse AG

Equities

1SXP

DE000A3ENQ51

Real-time Estimate Tradegate Other stock markets 12:30:46 2024-06-14 pm EDT			5-day change	1st Jan Change
27.49 ^EUR	+0.62%		-0.43%	-17.87%

Jun. 05	SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion	CI
May. 28	SCHOTT PHARMA : Berenberg reiterates its Neutral rating	ZD

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary	07:00am	EQ
Expanding prefillable glass syringe output: SCHOTT Pharma opens state of the art production facility in Lukácsháza, Hungary	Jun. 11	PU
Simplifying Subcutaneous Drug Administration, SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion	Jun. 06	AQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 23	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 23	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 17	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 17	EQ
SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes	May. 14	EQ
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes	May. 14	EQ
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations	Apr. 30	EQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina	Mar. 19	AQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility	Mar. 18	EQ
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda	Mar. 14	EQ
DD: SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell	Mar. 04	EQ
SCHOTT Pharma reports good start into fiscal year 2024	Feb. 29	EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	Feb. 26	EQ
SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory	Jan. 26	EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Jan. 15	EQ
SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance	Dec. 19	EQ
Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company	Dec. 06	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases SCHOTT Pharma AG & Co. KGaA Deutsche Boerse AG

Equities

1SXP

DE000A3ENQ51

Press Releases

Filters